secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001013762-25-001309
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio to host Q4 2024 conference call on March 27
------------------------------------------------------

- Conference call scheduled for March 27, 2025, at 4:30 p.m. ET to discuss Q4 2024 results and corporate update.
- Dial-in: 1-800-225-9448 or 1-203-518-9708; Conference ID: INMUNE.
- Webcast available via provided link; transcript and replay available afterward.
- No financial results disclosed in this filing; results will be released during the call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000101376225001309/0001013762-25-001309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000101376225001309/ea0234771-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001013762-25-001309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer